Parainfluenza Virus Infection Drugs Market Size 2032 | ModernaTX Inc., MedImmune LLC, Ansun Biopharma Inc., AlloVir, CyanVac LLC, QIAGEN Gaithersburg Inc., Novartis, Pfizer, Brazion Therapeutic, and others

DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as well as the Parainfluenza Virus Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Discover which therapies are expected to grab the Parainfluenza Virus Infection Market Share @ Parainfluenza Virus Infection Market Outlook- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Parainfluenza Virus Infection Market
• According to Hetrich et al. (2023), 41 of 175 (23.4%) households had individuals with HPIV-3 (n = 45) or RSV (n = 46) infections. Among children aged 0-4 years, RI IRs /1000 person-weeks were 8.7 [6.0, 12.2] for HPIV-3, 7.6 [4.8, 11.4] for RSV, and 1.9 [1.0, 3.5] for SARS-CoV-2. Children aged 0-4 years accounted for 35 of 36 primary HPIV-3 or RSV cases. Children attending childcare or preschool had higher odds of primary infection.
• The leading Parainfluenza Virus Infection Companies working in the market include ModernaTX Inc., MedImmune LLC, Ansun Biopharma Inc., AlloVir, CyanVac LLC, QIAGEN Gaithersburg Inc., Novartis, Pfizer, Brazion Therapeutic, and others.
• Promising Parainfluenza Virus Infection Pipeline Therapies in the various stages of development include mRNA-1653, MEDI-534, DAS181 dry powder, formulation F02, DAS181, and others.

Parainfluenza Virus Infection Overview
The human Parainfluenza virus (HPIV) is an enveloped, negative-sense, single-stranded RNA virus that belongs to the family of Paramyxoviridae. HPIV can cause both upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI) in children, usually under the age of 5, immunocompromised adults, and the elderly.

Parainfluenza Virus Infection Epidemiology Segmentation in the 7MM
• Total Parainfluenza Virus Infection Prevalent Cases 58in the US
• Total Parainfluenza Virus Infection Diagnosed Prevalent Cases in the US
• Total Parainfluenza Virus Infection Prevalent Cases Based on the Serotypes in the US
• Total Parainfluenza Virus Infection Prevalent Cases in Hematopoietic Stem Cell Transplant (HSCTs) Patients in the US
• Total Parainfluenza Virus Infection Treated Cases in the US

Download the report to understand which factors are driving Parainfluenza Virus Infection Epidemiology trends @ Parainfluenza Virus Infection Prevalence- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Parainfluenza Virus Infection Treatment Market Landscape
Parainfluenza Virus Infection treatment or prevention options for patients with PIV are limited as there are no approved antivirals or vaccines. Treatment of HPIV infection is generally symptomatic in healthy children and adults. Croup, commonly caused by HPIV1 and HPIV2 infection, presents with symptoms of a barking cough and stridor due to swelling and obstruction in the subglottic area of the trachea. Corticosteroids are the primary treatment for croup and have been shown to be beneficial for mild and moderate to severe croup. Among less ill children, corticosteroid treatment results in shorter emergency room visits, less frequent return medical visits, and improved sleep.

Parainfluenza Virus Infection Market Dynamics
The Parainfluenza Virus Infection market dynamics is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period of 2024- 2034.

Discover DelveInsight's comprehensive coverage of the Parainfluenza Virus Infection Market, offering unparalleled insights into projected Market Size and meticulous Market Forecast predictions. Stay informed on breakthroughs in Drugs Market advancements and Treatment Market strategies to capitalize on future opportunities effectively. @ Parainfluenza Virus Infection Treatment Drug Market Share-

Parainfluenza Virus Infection Drugs Uptake
• DAS181 is a recombinant sialidase protein that can cleave sialic acid, the virus receptors located on the surface of epithelial cells lining the human respiratory tract. This interrupts the virus lifecycle and allows patients the chance to recover. By targeting the host rather than the virus, DAS181 is less susceptible to drug-resistant strains of the virus, and by targeting the host rather than a specific virus, DAS181 works for other viruses that use sialic acid receptors, such as parainfluenza virus, human metapneumovirus, and enterovirus.

• ALVR106 is an allogeneic, off-the-shelf, multi-virus specific VST therapy candidate designed to target diseases caused by human metapneumovirus (hMPV), influenza, parainfluenza virus (PIV) and respiratory syncytial virus (RSV). In vitro data demonstrate that ALVR106 reactive cells have antiviral activity against each of the target viruses with minimal or no activity against non-virus-infected cells. A Phase I/II study evaluating the safety and antiviral activity of ALVR106 in post-transplant patients with respiratory viral infections is ongoing.

Parainfluenza Virus Infection Market Insights
"HPIVs cause a significant burden of disease in children and adults. A wide spectrum of illness including colds, croup, bronchiolitis, and pneumonia are attributed to these ubiquitous pathogens. The most severe disease is found among immune com promised patients and treatment at present remains largely supportive. Continued research for new vaccines and therapeutics is needed." Parainfluenza Virus Infection (PIV) pipeline is very weak with only a single pipeline product in the Phase III developmental stage of clinical trials. The product displays potential of launch in the market.

Stay ahead in the dynamic Parainfluenza Virus Infection Market landscape. Leverage DelveInsight's expert analysis to understand Market Size trends, predict future Market Forecast, and align your strategies with the shifting dynamics of the Drugs Market and Treatment Market @ Parainfluenza Virus Infection Market Drivers and Barriers

Scope of the Parainfluenza Virus Infection Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Parainfluenza Virus Infection Companies- ModernaTX Inc., MedImmune LLC, Ansun Biopharma Inc., AlloVir, CyanVac LLC, QIAGEN Gaithersburg Inc., Novartis, Pfizer, Brazion Therapeutic, and others.
• Parainfluenza Virus Infection Pipeline Therapies- mRNA-1653, MEDI-534, DAS181 dry powder, formulation F02, DAS181, and others.
• Parainfluenza Virus Infection Market Dynamics: Parainfluenza Virus Infection Market Drivers and Barriers

Discover more about Parainfluenza Virus Infection Drugs in development @ Parainfluenza Virus Infection Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Parainfluenza Virus Infection Executive Summary
3. Parainfluenza Virus Infection Competitive Intelligence Analysis
4. Parainfluenza Virus Infection: Market Overview at a Glance
5. Parainfluenza Virus Infection: Disease Background and Overview
6. Patient Journey
7. Parainfluenza Virus Infection Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Parainfluenza Virus Infection Unmet Needs
10. Key Endpoints of Parainfluenza Virus Infection Treatment
11. Parainfluenza Virus Infection Marketed Products
12. Parainfluenza Virus Infection Emerging Therapies
13. Parainfluenza Virus Infection: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Parainfluenza Virus Infection Market Outlook
16. Parainfluenza Virus Infection Market Access and Reimbursement Overview
17. Parainfluenza Virus Infection KOL Views
18. Parainfluenza Virus Infection Market Drivers
19. Parainfluenza Virus Infection Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2024

Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Cancer Therapy Market- https://www.delveinsight.com/report-store/cancer-therapy-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Methicillin-resistant Staphylococcus Aureus Mrsa Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
Rhinosinusitis Market- https://www.delveinsight.com/report-store/rhinosinusitis-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Wilms Tumor Market- https://www.delveinsight.com/report-store/wilms-tumor-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Cold Agglutinin Disease Market- https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Radiation Dermatitis Market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
Synovial Sarcoma Market- https://www.delveinsight.com/report-store/synovial-sarcoma-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Diabetic Nephropathy Market- https://www.delveinsight.com/report-store/diabetic-nephropathy-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Pcsk9 Inhibitors Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Chemotherapy Induced Neutropenia Market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Primary Biliary Cholangitis Market- https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Membranous Nephropathy Market- https://www.delveinsight.com/report-store/membranous-nephropathy-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Post Operative Pain Market- https://www.delveinsight.com/report-store/postoperative-pain-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Axillary Hyperhidrosis Market- https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors.

Contact Us
Yash Bhardwaj
info@delveinsight.com

This release was published on openPR.